semaglutide 2.0 mg approval Novo Nordisk's weight-loss pill wins FDA Semaglutide Approved for Type 2

You can do your part to stick it to COVID and keep yourself and the community safe by getting vaccinated

Metabolic profiling of PPAR / mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation

[15] [27] In October 2025, the FDA further expanded the indication for semaglutide (as Rybelsus) to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes who are at high risk for these events

"As the panel noted, they were struck by the amount of care Alberto took to ensure he was complying with the World Anti-Doping Code," Nike said

Insurance coverage for Wegovy remains limited and inconsistent

Back & Flanks Achieve a smoother, more toned back profile